For healthcare professionals

Bring neuromodulation to your practice.

rTMS has over 40 years of scientific backing and FDA approval for treatment-resistant major depression. NIBBOT technology puts that power in your office — portable, certified, and with ongoing support.

Request a demo Talk to an advisor

The gap that already exists in your practice

There are patients in your clinic that medication isn't reaching.

This isn't a marginal niche. It's a significant proportion of your current clinical base. NIBBOT gives you a concrete tool for them.

  • 30%

    of patients with depression do not respond to two or more lines of pharmacological treatment.

    WHO / Pascual-Leone et al., Rev Neurol 2008

  • 300M

    people worldwide live with depression. It is the leading cause of global disability.

    WHO, 2023

  • +10

    neuropsychiatric conditions in which rTMS has demonstrated clinically relevant results in controlled studies.

    Pascual-Leone et al., Rev Neurol 2008

Those patients are already in your practice. They've spent months — or years — without a satisfactory response. They've changed medications, done therapy, followed your guidance. And still, results haven't come.

rTMS doesn't replace your clinical judgment or your current protocol. It complements it with a non-pharmacological, non-invasive, evidence-backed option — one that until recently was only available in highly specialized hospital centers.

Clinical applications

Conditions in which rTMS has been studied

The information below is directed exclusively at healthcare professionals. Each protocol must be prescribed and implemented under qualified clinical judgment.

  • Treatment-resistant depression

    FDA approval for MDD without response to ≥ 2 antidepressants. Standard protocol: left DLPFC stimulation, 20–30 sessions.

    Rodríguez Hernández et al. Cureus 2024. DOI: 10.7759/cureus.59612

  • Generalized anxiety and PTSD

    Modulation of overactivated areas via low-frequency rTMS. Reduction of hyperactivation and chronic alarm response.

    Pulsed Magnetic Field Treatment of Anxiety, Panic and PTSD. DOI: 10.24966/ACIM-7562/100075

  • OCD

    Targeting of corticosubcortical circuits in the obsessive loop. Reduction of intrusive thoughts and compulsive behaviors.

    Pascual-Leone A, Tormos-Muñoz JM. Rev Neurol 2008; 46(Supl 1): S3-S10.

  • ADHD / Hyperactivity

    Prefrontal cortex stimulation to improve attentional regulation and inhibitory control. Complement to pharmacological or psychotherapeutic management.

    Pascual-Leone A, Tormos-Muñoz JM. Rev Neurol 2008; 46(Supl 1): S3-S10.

  • Insomnia

    Regulation of the circadian cycle and reduction of nocturnal cortical hyperactivation. Useful in patients with chronic insomnia or insomnia associated with mood disorders.

    Pascual-Leone A, Tormos-Muñoz JM. Rev Neurol 2008; 46(Supl 1): S3-S10.

  • Chronic pain and migraine

    Modulation of pain circuits at the cortical level. Reduction of frequency and intensity in migraine, fibromyalgia, and neuropathic pain.

    Migraña: DOI: 10.1007/BF02850298 · Fibromialgia: DOI: 10.1155/2013/270183

  • Parkinson's disease

    Complement to pharmacological treatment. Li-rTMS evaluated for improvement in mobility, rigidity, and quality of life in early to moderate stages.

    nibbot-tms.com/tratamiento-parkinson

  • Alzheimer's and cognitive decline

    Stimulation of memory and cognitive processing neural networks. Promising results in early stages to slow cognitive deterioration.

    DOI: 10.1344/joned.v5i2.47351

  • Neurological rehabilitation

    Post-stroke, TBI, and neurological injuries. Enhances neuroplasticity for recovery of speech, coordination, and motor function.

    DOI: 10.1038/s41598-017-12371-x

  • Fibromyalgia

    Reduction of generalized chronic pain through cortical modulation. Reported improvement in quality of life and functionality in controlled studies.

    DOI: 10.1155/2013/270183

Cutting-edge technology, within reach of your practice

NIBBOT Pro Series V24

Designed for private clinics and offices: portable, intuitive, and remotely updatable. Includes 24 preloaded clinical protocols — ready to use from day one.

  • 24 preloaded protocols — standard, paired, and Theta burst. No manual configuration or additional costs per protocol.
  • Remote software updates — no technician visits, no disruption to your clinical schedule.
  • ISO 13485:2016 certification — international standard for quality medical devices.
  • Endorsement by the Mexican Society of Neuromodulation — backing from the specialized scientific community.
  • 2 coils included — figure-8 (butterfly) for focal cranial stimulation, and circular for cranial and body applications.
  • 24-month warranty, extendable to 36.

Technical specifications

Frequency 1 Hz – 600 Hz
Magnetic flux 1 G – 600 G
Precision 99 ± 0.5%
Pulse type Monophasic / Biphasic
Operating modes Continuous / Paired / Theta Burst
Protocols 24 preloaded
Display 7 inches
Weight 6.0 kg
Power supply 110 V / 220 V
Certification ISO 13485:2016
Warranty 24 months (extendable to 36)

From day one

You don't just receive a device. You receive a support team.

The clinical and commercial success of NIBBOT in your practice depends on using it well. That's why onboarding and ongoing support are included — at no additional cost.

  • Initial training

    In-person or remote training for your clinical team. You'll learn to operate the device, select protocols, and manage sessions from day one.

  • Clinical protocols included

    24 preloaded protocols, developed with clinical expertise. Ready to apply — no manual configuration or additional investment per condition or specialty.

  • Remote updates

    The device software is updated remotely, automatically, and at no cost. Your device always runs the latest version without disrupting clinical operations.

  • Specialized technical support

    Access to technical support from neuromodulation specialists. Not a generic call center — professionals who know the device and the clinical context.

  • Clinical materials

    Supporting bibliography, informed consent forms, clinical follow-up guides, and patient-facing communication materials.

  • NIBBOT professional network

    By integrating NIBBOT, you become part of the certified center network. Visibility to patients seeking treatment in your geographic area.

Return on investment

No consumables. No per-protocol licenses. No surprises.

NIBBOT's model is designed so the device pays for itself — and generates additional revenue for your practice without significantly increasing your clinical workload.

  • No consumables

    Each session requires no disposable materials. The marginal cost per session is practically zero once the device is amortized.

  • 24 protocols included

    You don't pay per condition you treat. All 24 clinical protocols are included with the device — no additional licenses.

  • Patient retention

    Patients who previously had no options now have a reason to stay in your practice. Less turnover, greater adherence.

Estimated usage scenarios

Session price values vary by market, specialty, and practice model. This table illustrates the potential volume of sessions — speak with an advisor to calculate the specific return for your context.

Early-stage practice

2 sessions / day

~40 sessions / month

Ideal for beginning to integrate NIBBOT with selected patients

Standard practice

5 sessions / day

~100 sessions / month

Most common model in clinics integrating NIBBOT as a regular service

Active practice

10 sessions / day

~200 sessions / month

For centers with partial or full dedication to neuromodulation

Note: The figures above are for reference only. Actual return depends on the session price in your market, your patient profile, and your practice volume. Request a consultation with our team for a personalized analysis.

The next step is a conversation.

Schedule a no-commitment demo and see how NIBBOT integrates into your practice — from patient selection to the first protocol.

Request a demo Talk to an advisor